Cargando…
Subjective Overview of Accelerated Aging in Schizophrenia
Schizophrenia, like many other human diseases, particularly neuropsychiatric diseases, shows evidence of accelerated brain aging. The molecular nature of the process of aging is unknown but several potential indicators have been used in research. The concept of accelerated aging in schizophrenia too...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819113/ https://www.ncbi.nlm.nih.gov/pubmed/36613059 http://dx.doi.org/10.3390/ijerph20010737 |
_version_ | 1784865151263965184 |
---|---|
author | Seeman, Mary V. |
author_facet | Seeman, Mary V. |
author_sort | Seeman, Mary V. |
collection | PubMed |
description | Schizophrenia, like many other human diseases, particularly neuropsychiatric diseases, shows evidence of accelerated brain aging. The molecular nature of the process of aging is unknown but several potential indicators have been used in research. The concept of accelerated aging in schizophrenia took hold in 2008 and its timing, pace, determinants and deterrents have been increasingly examined since. The present overview of the field is brief and selective, based on diverse studies, expert opinions and successive reviews. Current thinking is that the timing of age acceleration in schizophrenia can occur at different time periods of the lifespan in different individuals, and that antipsychotics may be preventive. The majority opinion is that the cognitive decline and premature death often seen in schizophrenia are, in principle, preventable. |
format | Online Article Text |
id | pubmed-9819113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98191132023-01-07 Subjective Overview of Accelerated Aging in Schizophrenia Seeman, Mary V. Int J Environ Res Public Health Review Schizophrenia, like many other human diseases, particularly neuropsychiatric diseases, shows evidence of accelerated brain aging. The molecular nature of the process of aging is unknown but several potential indicators have been used in research. The concept of accelerated aging in schizophrenia took hold in 2008 and its timing, pace, determinants and deterrents have been increasingly examined since. The present overview of the field is brief and selective, based on diverse studies, expert opinions and successive reviews. Current thinking is that the timing of age acceleration in schizophrenia can occur at different time periods of the lifespan in different individuals, and that antipsychotics may be preventive. The majority opinion is that the cognitive decline and premature death often seen in schizophrenia are, in principle, preventable. MDPI 2022-12-31 /pmc/articles/PMC9819113/ /pubmed/36613059 http://dx.doi.org/10.3390/ijerph20010737 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Seeman, Mary V. Subjective Overview of Accelerated Aging in Schizophrenia |
title | Subjective Overview of Accelerated Aging in Schizophrenia |
title_full | Subjective Overview of Accelerated Aging in Schizophrenia |
title_fullStr | Subjective Overview of Accelerated Aging in Schizophrenia |
title_full_unstemmed | Subjective Overview of Accelerated Aging in Schizophrenia |
title_short | Subjective Overview of Accelerated Aging in Schizophrenia |
title_sort | subjective overview of accelerated aging in schizophrenia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819113/ https://www.ncbi.nlm.nih.gov/pubmed/36613059 http://dx.doi.org/10.3390/ijerph20010737 |
work_keys_str_mv | AT seemanmaryv subjectiveoverviewofacceleratedaginginschizophrenia |